603456 九洲药业
已收盘 07-16 15:00:00
资讯
新帖
简况
九洲药业:完成工商变更登记注册资本减至捌亿捌仟玖佰肆拾肆万陆仟零贰拾捌元
公司公告 · 07-09
九洲药业:完成工商变更登记注册资本减至捌亿捌仟玖佰肆拾肆万陆仟零贰拾捌元
CRO概念盘中跳水,华测检测跌0.52%
市场透视 · 07-02
CRO概念盘中跳水,华测检测跌0.52%
九洲药业获得发明专利授权:“一种右美沙芬的合成方法”
证券之星 · 07-01
九洲药业获得发明专利授权:“一种右美沙芬的合成方法”
九洲药业:控股子公司获得枸橼酸西地那非口崩片药品注册证书
蓝鲸财经 · 07-01
九洲药业:控股子公司获得枸橼酸西地那非口崩片药品注册证书
中国创新药能否持续让世界买单?券商分析师最新观点
券商中国 · 06-30
中国创新药能否持续让世界买单?券商分析师最新观点
九洲药业:持续供应诺欣妥中间体及原料药
证券之星 · 06-30
九洲药业:持续供应诺欣妥中间体及原料药
每周股票复盘:九洲药业(603456)注销5789800股已回购股份
证券之星 · 06-28
每周股票复盘:九洲药业(603456)注销5789800股已回购股份
九洲药业06月26日遭主力抛售2761.2万元
市场透视 · 06-26
九洲药业06月26日遭主力抛售2761.2万元
CRO概念盘中跳水,诚达药业跌1.43%
市场透视 · 06-26
CRO概念盘中跳水,诚达药业跌1.43%
九洲药业闪耀CPHI China 2025,加速全球市场拓展
九洲药业 · 06-25
九洲药业闪耀CPHI China 2025,加速全球市场拓展
九洲药业06月25日遭主力抛售851.6万元
市场透视 · 06-25
九洲药业06月25日遭主力抛售851.6万元
长城基金谭小兵钟情白酒股,旗下基金亏损40%,基民质疑何时能回本?
市场资讯 · 06-24
长城基金谭小兵钟情白酒股,旗下基金亏损40%,基民质疑何时能回本?
九洲药业06月23日主力净流入1194.0万元 散户资金抛售
市场透视 · 06-23
九洲药业06月23日主力净流入1194.0万元 散户资金抛售
九洲药业荣登2025中国医药CDMO企业20强
九洲药业 · 06-21
九洲药业荣登2025中国医药CDMO企业20强
XD九洲药06月19日遭主力抛售1053.0万元
市场透视 · 06-19
XD九洲药06月19日遭主力抛售1053.0万元
CRO概念盘中拉升,和元生物涨0.51%
市场透视 · 06-19
CRO概念盘中拉升,和元生物涨0.51%
九洲药业06月17日遭主力抛售4239.9万元
市场透视 · 06-17
九洲药业06月17日遭主力抛售4239.9万元
九洲药业06月16日遭主力抛售3758.0万元
市场透视 · 06-16
九洲药业06月16日遭主力抛售3758.0万元
九洲药业06月13日主力净流出4165.2万元 散户资金买入
市场透视 · 06-13
九洲药业06月13日主力净流出4165.2万元 散户资金买入
CRO概念盘中跳水,九洲药业跌0.76%
市场透视 · 06-13
CRO概念盘中跳水,九洲药业跌0.76%
加载更多
公司概况
公司名称:
浙江九洲药业股份有限公司
所属行业:
医药制造业
上市日期:
2014-10-10
主营业务:
浙江九洲药业股份有限公司的主营业务是为全球制药公司、生物科技公司、科研机构等提供一站式的医药定制研发和生产(CDMO)服务,包含小分子化学药物、多肽药物、偶联药物和小核酸药物。公司的主要产品是合同定制类、抗感染类、中枢神经类药物、非甾体类药物、降血糖类药。报告期内,公司荣获2024中国医药CDMO企业20强、2023年度中国医药工业百强系列榜单-2023年度中国CXO企业TOP20、浙江省生物医药产业领军型企业等多项荣誉。
发行价格:
15.43
{"stockData":{"symbol":"603456","market":"SH","secType":"STK","nameCN":"九洲药业","latestPrice":16.32,"timestamp":1752649200000,"preClose":16.38,"halted":0,"volume":18911404,"delay":0,"changeRate":-0.0037,"floatShares":889000000,"shares":889000000,"eps":0.6966,"marketStatus":"已收盘","change":-0.06,"latestTime":"07-16 15:00:00","open":16.37,"high":16.45,"low":16.13,"amount":308000000,"amplitude":0.0195,"askPrice":16.33,"askSize":1345,"bidPrice":16.32,"bidSize":328,"shortable":0,"etf":0,"ttmEps":0.6966,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752715800000},"marketStatusCode":5,"adr":0,"adjPreClose":16.38,"symbolType":"stock","openAndCloseTimeList":[[1752629400000,1752636600000],[1752642000000,1752649200000]],"highLimit":18.02,"lowLimit":14.74,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":889446028,"isCdr":false,"pbRate":1.65,"roa":"--","peRate":23.428079,"roe":"2.89%","epsLYR":0.68,"committee":-0.126928,"marketValue":14516000000,"turnoverRate":0.0213,"status":1,"floatMarketCap":14516000000},"requestUrl":"/m/hq/s/603456","defaultTab":"news","newsList":[{"id":"2550681843","title":"九洲药业:完成工商变更登记注册资本减至捌亿捌仟玖佰肆拾肆万陆仟零贰拾捌元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550681843","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550681843?lang=zh_cn&edition=full","pubTime":"2025-07-09 15:48","pubTimestamp":1752047288,"startTime":"0","endTime":"0","summary":"九洲药业公告,公司已完成工商变更登记手续,注册资本变更为捌亿捌仟玖佰肆拾肆万陆仟零贰拾捌元,并修订《公司章程》相关条款。公司取得浙江省市场监督管理局换发的《营业执照》,其他信息包括公司类型为其他股份有限公司(上市),法定代表人为花莉蓉,成立日期为1998年07月13日,经营范围涵盖化学 原料药 、医药中间体等领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709155924a43fcd94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709155924a43fcd94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603456","BK0070","BK0239"],"gpt_icon":0},{"id":"2548738830","title":"CRO概念盘中跳水,华测检测跌0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548738830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548738830?lang=zh_cn&edition=full","pubTime":"2025-07-02 10:11","pubTimestamp":1751422312,"startTime":"0","endTime":"0","summary":"07月02日,CRO概念盘中跳水,截至10点11分,CRO概念整体指数下跌1.08%,报473.020点。从个股上来看,该概念的成分股中,华测检测跌0.52%,迦南科技、太龙药业、九洲药业跌幅居前。从资金上来看,截止发稿,CRO概念主力净流入为-1.64亿,其中药明康德受到资金热捧,主力净流入2500.88万;拉长时间线来看,该板块近20日主力资金净流入-47.66亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070210115295335073&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070210115295335073&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1820825898.SGD","BK0132","LU1146622755.USD","BK0159","LU2460026573.USD","603456","BK0239","600222","BK0188","300012","BK0221","LU0227179875.USD"],"gpt_icon":0},{"id":"2548881773","title":"九洲药业获得发明专利授权:“一种右美沙芬的合成方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2548881773","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548881773?lang=zh_cn&edition=full","pubTime":"2025-07-02 02:28","pubTimestamp":1751394496,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示九洲药业新获得一项发明专利授权,专利名为“一种右美沙芬的合成方法”,专利申请号为CN202310333994.8,授权日为2025年7月1日。今年以来九洲药业新获得专利授权11个,较去年同期增加了57.14%。通过天眼查大数据分析,浙江九洲药业股份有限公司共对外投资了26家企业,参与招投标项目21次;财产线索方面有商标信息58条,专利信息248条;此外企业还拥有行政许可17个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070200002324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","603456"],"gpt_icon":0},{"id":"2548653075","title":"九洲药业:控股子公司获得枸橼酸西地那非口崩片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2548653075","media":"蓝鲸财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548653075?lang=zh_cn&edition=full","pubTime":"2025-07-01 15:45","pubTimestamp":1751355901,"startTime":"0","endTime":"0","summary":"蓝鲸新闻7月1日电,九洲药业 公告称,公司控股子公司浙江九洲生物医药有限公司收到国家药品监督管理局核准签发的枸橼酸西地那非口崩片的《药品注册证书》。九洲药业已在枸橼酸西地那非口崩片累计研发投入约为人民币1,352万元。本次取得该药品注册证书,进一步丰富公司产品管线,有助于提升公司产品的市场竞争力,但短期内不会对公司业绩产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070115474295324224&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070115474295324224&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","603456","BK0239"],"gpt_icon":0},{"id":"2547015164","title":"中国创新药能否持续让世界买单?券商分析师最新观点","url":"https://stock-news.laohu8.com/highlight/detail?id=2547015164","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547015164?lang=zh_cn&edition=full","pubTime":"2025-06-30 23:29","pubTimestamp":1751297340,"startTime":"0","endTime":"0","summary":"医药魔方统计,2025年1—5月,中国创新药企对外授权交易总金额已达455亿美元,超过2024年上半年的交易总额,创新药出海授权交易大爆发。亮眼数据的背后,是中国创新药整体水平的强势崛起。“中国创新药产业的研发、临床与生产能力,正处于与国际一线水平接轨的初始阶段。”由于BD数据不及预期,年内大涨明显的创新药企业荣昌生物股价近期大幅回调,从而带动创新药板块整体调整。华泰柏瑞恒生创新药ETF6月中旬以来一度单周下行超过8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600079","688520","603259","600521","603087","600422","600998","600557","688068","688198","603229","603367","688177","605199","600056","603590","600513","600216","603707","600222","688181","600682","688356","688321","ONC","600380","603567","688506","159992","600267","688336","688505","601089","688488","603127","600196","688136","688331","688117","688091","600881","688317","603456","688073","600351","600535","600420","688319","600332","688189","688235","600721","688513","600851","600276","601607","600572","688131","600867","600200","600774","603716","600789","600080","688222","BK0239","688278","06160","603998","688202","600062","600645","688166","688163"],"gpt_icon":0},{"id":"2547650000","title":"九洲药业:持续供应诺欣妥中间体及原料药","url":"https://stock-news.laohu8.com/highlight/detail?id=2547650000","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547650000?lang=zh_cn&edition=full","pubTime":"2025-06-30 16:36","pubTimestamp":1751272601,"startTime":"0","endTime":"0","summary":"证券之星消息,九洲药业06月30日在投资者关系平台上答复投资者关心的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025063000021346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603456","BK0070"],"gpt_icon":0},{"id":"2547070916","title":"每周股票复盘:九洲药业(603456)注销5789800股已回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2547070916","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547070916?lang=zh_cn&edition=full","pubTime":"2025-06-29 04:46","pubTimestamp":1751143569,"startTime":"0","endTime":"0","summary":"截至2025年6月27日收盘,九洲药业报收于14.41元,较上周的14.13元上涨1.98%。本周,九洲药业6月25日盘中最高价报14.53元。本周关注点公司公告汇总: 浙江九洲药业股份有限公司将于2025年6月26日注销5789800股已回购股份公司公告汇总浙江九洲药业股份有限公司发布关于注销部分已回购股份的实施公告。本次注销完成后,公司总股本将由895235828股减少至889446028股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062900000891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603456","BK0239","BK0070"],"gpt_icon":0},{"id":"2546202055","title":"九洲药业06月26日遭主力抛售2761.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546202055","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546202055?lang=zh_cn&edition=full","pubTime":"2025-06-26 15:20","pubTimestamp":1750922415,"startTime":"0","endTime":"0","summary":"06月26日, 九洲药业股价跌1.25%,报收14.19元,成交金额1.8亿元,换手率1.45%,振幅1.39%,量比0.89。九洲药业今日主力资金净流出2761.2万元,连续3日净流出,上一交易日主力净流出851.6万元。|06月26日主力加仓幅度排名||#|股票简称|主力净额占比|#|欢瑞世纪|6.52%|#|华锋股份|6.02%|#|科创信息|5.98%|#|...|...|#4314|九洲药业|-0.22%|九洲药业所在的医疗服务行业,今日主力净流出6.96亿元,行业排名17/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626163816a4bed076&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626163816a4bed076&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603456","BK0070","BK0239"],"gpt_icon":0},{"id":"2546327523","title":"CRO概念盘中跳水,诚达药业跌1.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546327523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546327523?lang=zh_cn&edition=full","pubTime":"2025-06-26 09:43","pubTimestamp":1750902198,"startTime":"0","endTime":"0","summary":"06月26日,CRO概念盘中跳水,截至09点43分,CRO概念整体指数下跌2.02%,报441.210点。从个股上来看,该概念的成分股中,诚达药业跌1.43%,百花医药、九洲药业、泰格医药跌幅居前。从资金上来看,截止发稿,CRO概念主力净流入为-1.34亿,其中诺思格受到资金热捧,主力净流入481.08万;拉长时间线来看,该板块近20日主力资金净流入-46.36亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626094318a71df456&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626094318a71df456&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","603456","301201","BK0239","600721"],"gpt_icon":0},{"id":"2546216901","title":"九洲药业闪耀CPHI China 2025,加速全球市场拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=2546216901","media":"九洲药业","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546216901?lang=zh_cn&edition=full","pubTime":"2025-06-25 17:50","pubTimestamp":1750845009,"startTime":"0","endTime":"0","summary":"作为创新驱动型CDMO企业,九洲药业始终以全球市场趋势为导向,持续拓宽服务边界。本次展会,九洲药业围绕重点产品、市场体系和行业动态与全球客户展开广泛探讨。展望未来,九洲药业将继续秉持创新驱动理念,加速国际化进程,与行业同仁携手共探高质量发展之路,为全球医药事业蓬勃发展贡献力量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625175509a4bd1f58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625175509a4bd1f58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603456","BK0070"],"gpt_icon":0},{"id":"2546297841","title":"九洲药业06月25日遭主力抛售851.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546297841","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546297841?lang=zh_cn&edition=full","pubTime":"2025-06-25 15:19","pubTimestamp":1750835988,"startTime":"0","endTime":"0","summary":"06月25日, 九洲药业股价跌0.69%,报收14.37元,成交金额2.7亿元,换手率2.10%,振幅2.42%,量比1.27。九洲药业今日主力资金净流出851.6万元,上一交易日主力净流出1004.7万元。该股近5个交易日上涨0.45%,主力资金累计净流出2298.6万元;近20日主力资金累计净流出2.8亿元,其中净流出天数为15日。|06月25日主力加仓幅度排名||#|股票简称|主力净额占比|#|天晟新材|11.04%|#|新力金融|7.66%|#|北方长龙|7.56%|#|...|...|#3393|九洲药业|-0.07%|九洲药业所在的医疗服务行业,今日主力净流出2.47亿元,行业排名33/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625164648a4bcfb1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625164648a4bcfb1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0239","603456"],"gpt_icon":0},{"id":"2545478822","title":"长城基金谭小兵钟情白酒股,旗下基金亏损40%,基民质疑何时能回本?","url":"https://stock-news.laohu8.com/highlight/detail?id=2545478822","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545478822?lang=zh_cn&edition=full","pubTime":"2025-06-24 10:19","pubTimestamp":1750731540,"startTime":"0","endTime":"0","summary":"笔者发现,长城基金经理谭小兵旗下基金产品出现亏损,这也进一步显示出长城基金在权益投资方面的短板。谭小兵累计任职时间9年又141天,目前管理基金总规模26.46亿元,在管基金最佳任期回报147.46%。笔者发现,谭经理旗下基金中长城健康生活混合A亏损最大,该基金成立于2020年8月14日,基金规模3.17亿元。2022年1季度持有65.61万股,2022年2季度持有47.67万股。2022年3季度持有51.72万股,2022年4季度持有38.80万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624102643a4ba96a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624102643a4ba96a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600519","LU1997245094.SGD","LU2495084118.USD","603259","LU1997245177.USD","LU2328871848.SGD","LU0456842615.SGD","BK0216","LU2488822045.USD","LU1969619763.USD","603529","603456","LU1997244956.HKD"],"gpt_icon":0},{"id":"2545491888","title":"九洲药业06月23日主力净流入1194.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2545491888","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545491888?lang=zh_cn&edition=full","pubTime":"2025-06-23 15:20","pubTimestamp":1750663252,"startTime":"0","endTime":"0","summary":"06月23日, 九洲药业股价涨1.34%,报收14.32元,成交金额1.9亿元,换手率1.48%,振幅2.12%,量比0.65。九洲药业今日主力资金净流入1194.0万元,上一交易日主力净流出583.2万元。该股近5个交易日下跌3.66%,主力资金累计净流出7198.9万元;近20日主力资金累计净流出2.0亿元,其中净流出天数为13日。|06月23日主力加仓幅度排名||#|股票简称|主力净额占比|#|逸豪新材|8.98%|#|大为股份|7.79%|#|C新恒汇|7.30%|#|...|...|#972|九洲药业|0.09%|九洲药业所在的医疗服务行业,今日主力净流入482万元,行业排名59/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623165554a4b89065&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623165554a4b89065&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603456","BK0070","BK0239"],"gpt_icon":0},{"id":"2545488455","title":"九洲药业荣登2025中国医药CDMO企业20强","url":"https://stock-news.laohu8.com/highlight/detail?id=2545488455","media":"九洲药业","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545488455?lang=zh_cn&edition=full","pubTime":"2025-06-21 15:53","pubTimestamp":1750492384,"startTime":"0","endTime":"0","summary":"6月20日,《2025中国药品研发实力排行榜》系列榜单在重庆重磅发布。九洲药业凭借硬核技术实力与全球化服务优势,再度跻身年度“中国医药CDMO企业20强”,同时荣获“2025中国化药研发实力排行榜Top100”,以双项荣誉夯实公司在医药研发生产服务领域的领先地位。使命驱动锚定全球医药创新未来“关爱生命,守护健康”是九洲药业始终坚守的使命。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621160113a4b5ebd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621160113a4b5ebd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0010","BK0188","BK0239","BK0082","BK0185","BK0070","BK0250","BK0175","600056","BK0028","603456"],"gpt_icon":0},{"id":"2544154822","title":"XD九洲药06月19日遭主力抛售1053.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544154822","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544154822?lang=zh_cn&edition=full","pubTime":"2025-06-19 15:20","pubTimestamp":1750317612,"startTime":"0","endTime":"0","summary":"06月19日, XD九洲药股价跌1.05%,报收14.15元,成交金额2.1亿元,换手率1.62%,振幅2.45%,量比0.49。XD九洲药今日主力资金净流出1053.0万元,连续5日净流出,上一交易日主力净流出2516.7万元。|06月19日主力加仓幅度排名||#|股票简称|主力净额占比|#|创新医疗|9.04%|#|凯旺科技|8.35%|#|海科新源|6.34%|#|...|...|#2857|XD九洲药|-0.08%|XD九洲药所在的医疗服务行业,今日主力净流出3.55亿元,行业排名53/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619165201a4b238d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619165201a4b238d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0239","603456"],"gpt_icon":0},{"id":"2544318713","title":"CRO概念盘中拉升,和元生物涨0.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544318713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544318713?lang=zh_cn&edition=full","pubTime":"2025-06-19 09:37","pubTimestamp":1750297024,"startTime":"0","endTime":"0","summary":"06月19日,CRO概念盘中拉升,截至09点37分,CRO概念整体指数上涨0.53%,报446.670点。从个股上来看,该概念的成分股中,和元生物涨0.51%,泰格医药、XD九洲药、皓元医药涨幅居前。从资金上来看,截止发稿,CRO概念主力净流入为-2416.30万,其中药明康德受到资金热捧,主力净流入718.80万;拉长时间线来看,该板块近20日主力资金净流入-40.65亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619093704a4b1909c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619093704a4b1909c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2495084118.USD","LU1997245177.USD","LU0456842615.SGD","603456","LU1997245094.SGD","BK0216","LU1969619763.USD","603259","LU1997244956.HKD","LU2488822045.USD","688238","LU2328871848.SGD"],"gpt_icon":0},{"id":"2544952553","title":"九洲药业06月17日遭主力抛售4239.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544952553","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544952553?lang=zh_cn&edition=full","pubTime":"2025-06-17 15:20","pubTimestamp":1750144834,"startTime":"0","endTime":"0","summary":"06月17日, 九洲药业股价跌2.11%,报收14.84元,成交金额4.3亿元,换手率3.18%,振幅3.96%,量比0.92。九洲药业今日主力资金净流出4239.9万元,连续3日净流出,上一交易日主力净流出3758.0万元。|06月17日主力加仓幅度排名||#|股票简称|主力净额占比|#|胜通能源|8.61%|#|爱朋医疗|6.73%|#|融发核电|4.93%|#|...|...|#4700|九洲药业|-0.32%|九洲药业所在的医疗服务行业,今日主力净流出7.02亿元,行业排名15/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617170746a4adf1cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617170746a4adf1cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603456","BK0070"],"gpt_icon":0},{"id":"2543245676","title":"九洲药业06月16日遭主力抛售3758.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543245676","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543245676?lang=zh_cn&edition=full","pubTime":"2025-06-16 15:20","pubTimestamp":1750058417,"startTime":"0","endTime":"0","summary":"06月16日, 九洲药业股价跌1.81%,报收15.16元,成交金额4.2亿元,换手率3.06%,振幅2.78%,量比0.85。九洲药业今日主力资金净流出3758.0万元,上一交易日主力净流出4165.2万元。|06月16日主力加仓幅度排名||#|股票简称|主力净额占比|#|三维通信|7.93%|#|惠通科技|7.82%|#|天阳科技|6.26%|#|...|...|#4833|九洲药业|-0.28%|九洲药业所在的医疗服务行业,今日主力净流出3.04亿元,行业排名16/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616165249a4abac4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616165249a4abac4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","603456","BK0239"],"gpt_icon":0},{"id":"2543501153","title":"九洲药业06月13日主力净流出4165.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2543501153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543501153?lang=zh_cn&edition=full","pubTime":"2025-06-13 15:20","pubTimestamp":1749799221,"startTime":"0","endTime":"0","summary":"06月13日, 九洲药业股价跌2.77%,报收15.44元,成交金额6.6亿元,换手率4.72%,振幅4.22%,量比1.52。九洲药业今日主力资金净流出4165.2万元,上一交易日主力净流入1937.0万元。该股近5个交易日上涨4.32%,主力资金累计净流出1344.3万元;近20日主力资金累计净流出9433.0万元,其中净流出天数为12日。|06月13日主力加仓幅度排名||#|股票简称|主力净额占比|#|北方长龙|9.12%|#|通源石油|8.22%|#|海能达|5.30%|#|...|...|#4156|九洲药业|-0.30%|九洲药业所在的医疗服务行业,今日主力净流出12.34亿元,行业排名16/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613164358a707134b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613164358a707134b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603456","BK0239","BK0070"],"gpt_icon":0},{"id":"2543137527","title":"CRO概念盘中跳水,九洲药业跌0.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543137527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543137527?lang=zh_cn&edition=full","pubTime":"2025-06-13 09:58","pubTimestamp":1749779935,"startTime":"0","endTime":"0","summary":"06月13日,CRO概念盘中跳水,截至09点58分,CRO概念整体指数下跌1.15%,报469.720点。从个股上来看,该概念的成分股中,九洲药业跌0.76%,博腾股份、和元生物、昭衍新药跌幅居前。从资金上来看,截止发稿,CRO概念主力净流入为-1685.45万,其中诺泰生物受到资金热捧,主力净流入3919.86万;拉长时间线来看,该板块近20日主力资金净流入-7.34亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613095855a706687a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613095855a706687a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","603456","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752675220711,"stockEarnings":[{"period":"1week","weight":0.0595},{"period":"1month","weight":0.0828},{"period":"3month","weight":0.2514},{"period":"6month","weight":0.2851},{"period":"1year","weight":0.2581},{"period":"ytd","weight":0.2221}],"compareEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":0.0379},{"period":"3month","weight":0.0699},{"period":"6month","weight":0.0831},{"period":"1year","weight":0.1785},{"period":"ytd","weight":0.0457}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江九洲药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"53978人(较上一季度增加1.31%)","perCapita":"16477股","listingDate":"2014-10-10","address":"浙江省台州市椒江区外沙路99号","registeredCapital":"88944万元","survey":" 浙江九洲药业股份有限公司的主营业务是为全球制药公司、生物科技公司、科研机构等提供一站式的医药定制研发和生产(CDMO)服务,包含小分子化学药物、多肽药物、偶联药物和小核酸药物。公司的主要产品是合同定制类、抗感染类、中枢神经类药物、非甾体类药物、降血糖类药。报告期内,公司荣获2024中国医药CDMO企业20强、2023年度中国医药工业百强系列榜单-2023年度中国CXO企业TOP20、浙江省生物医药产业领军型企业等多项荣誉。","listedPrice":15.43},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九洲药业(603456)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九洲药业(603456)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九洲药业,603456,九洲药业股票,九洲药业股票老虎,九洲药业股票老虎国际,九洲药业行情,九洲药业股票行情,九洲药业股价,九洲药业股市,九洲药业股票价格,九洲药业股票交易,九洲药业股票购买,九洲药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九洲药业(603456)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九洲药业(603456)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}